Physician
The Phoenix Children's Center, LTD
The Phoenix Children's Center, LTD was paid $2.26M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoTHE PHOENIX CHILDREN'S CENTER, LTD
PHOENIX, AZ 85016
PHOENIX, AZ 85016
33aNPI1801985486assigned 10/12/2006
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$2.26M
24GClaims62,012
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Arizona
Rank by total paid#2 of 11
Median peer was paid$974K
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,543 | $516K | |
| 2019 | 13,793 | $486K | |
| 2020 | 9,911 | $366K | |
| 2021 | 5,872 | $272K | |
| 2022 | 6,056 | $220K | |
| 2023 | 6,233 | $222K | |
| 2024incomplete | 4,604 | $180K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 15,346 | 14,027 | $803K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 4,587 | 4,300 | $328K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 10,057 | 9,815 | $297K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.1% | 2,491 | 2,352 | $183K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.8% | 2,284 | 2,245 | $177K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.5% | 2,178 | 2,144 | $169K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.5% | 1,447 | 1,440 | $124K |
| 92552 | 1.7% | 3,160 | 2,992 | $40K | |
| 90461 | 1.1% | 2,068 | 2,006 | $25K | |
| 92081 | <1% | 1,541 | 1,455 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,226 | 1,172 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 792 | 561 | $15K |
33 more codes
| 96160 | <1% | 5,180 | $12K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 370 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 228 | $11K |
| 86328 | <1% | 247 | $10K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 402 | $10K |
| 99441 | <1% | 122 | $3K | |
| 99174 | <1% | 319 | $2K | |
| 0071A | <1% | 22 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $1K |
| 69210 | <1% | 29 | $983.83 | |
| 90480 | <1% | 43 | $917.65 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 41 | $640.78 |
| 0011A | <1% | 12 | $480.40 | |
| 99442 | <1% | 16 | $331.65 | |
| 90698 | <1% | 1,162 | $92.47 | |
| 96127 | <1% | 16 | $74.88 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 66 | $58.29 |
| 81002 | <1% | 14 | $42.71 | |
| 90686 | <1% | 3,648 | $19.89 | |
| 94760 | <1% | 23 | $15.84 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 41 | $4.02 |
| 90656 | 0% | 603 | $0.00 | |
| 90744 | 0% | 116 | $0.00 | |
| 90680 | 0% | 294 | $0.00 | |
| 90716 | 0% | 79 | $0.00 | |
| 90651 | 0% | 39 | $0.00 | |
| 90633 | 0% | 55 | $0.00 | |
| 90670 | 0% | 1,053 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 186 | $0.00 |
| 90685 | 0% | 114 | $0.00 | |
| 90655 | 0% | 148 | $0.00 | |
| 90707 | 0% | 107 | $0.00 | |
| 90734 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEDNICKY, BARBARA (OFFICER)